Dr Agarwal's Eye Hospital and Eye Research Centre, Chennai, India.
Eye (Lond). 2010 Jul;24(7):1143-8. doi: 10.1038/eye.2010.10. Epub 2010 Feb 12.
To evaluate the post-operative outcome of fibrin glue-assisted posterior chamber intraocular lens (IOL) implantation in eyes with deficient capsular support after 1 year.
Eyes operated with fibrin glue-assisted posterior chamber IOL implantation from December 2007 to May 2008 were included. The post-operative best spectacle-corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), intraocular pressure (IOP), central macular thickness, and specular count were evaluated. IOL position and centration at 1 year was determined. The 1-year post-operative complications were analysed.
A total of 53 eyes of 53 patients were analysed. There was significant improvement in UCVA (P=0.000) and BCVA (P=0.000). There was no significant change (P=0.447) in IOP from the pre-operative value. The early post-operative complication was decentration (5.6%). The late complication was pigment dispersion (3.7%) and healed macular oedema (7.5%). No vision threatening complications such as retinal break, retinal detachment, or endophthalmitis were seen. The percentage (%) loss of endothelial cells was 5.23+/-3.4% at 1-year follow-up. No pseudophakodonesis was seen in the follow-up visits.
Results obtained at 1 year after fibrin glue-assisted posterior chamber IOL implantation showed a good visual outcome with minimal complications in eyes with deficient capsular support.
评估 1 年后缺乏囊袋支持的后房型人工晶状体（IOL）植入术中应用纤维蛋白胶的术后效果。
纳入 2007 年 12 月至 2008 年 5 月间接受纤维蛋白胶辅助后房型 IOL 植入术的患者。评估术后最佳矫正视力（BCVA）、未矫正视力（UCVA）、眼压（IOP）、中心黄斑厚度和镜面计数。术后 1 年评估 IOL 位置和中心度。分析术后 1 年的并发症。
共分析了 53 例（53 只眼）患者的资料。UCVA（P=0.000）和 BCVA（P=0.000）均有显著改善。IOP 与术前相比无显著变化（P=0.447）。早期术后并发症为偏心（5.6%）。晚期并发症为色素播散（3.7%）和黄斑水肿愈合（7.5%）。未发生视网膜裂孔、视网膜脱离或眼内炎等威胁视力的并发症。术后 1 年时内皮细胞丢失率为 5.23±3.4%。随访中未见假性囊袋混浊。
在缺乏囊袋支持的患者中，纤维蛋白胶辅助后房型 IOL 植入术后 1 年获得了良好的视力结果，并发症较少。
